SUGIMOTO; Masamichi

Patent Applications and Registrations

Patent applications and USPTO patent grants for SUGIMOTO; Masamichi.The latest application filed is for "method and medicament for treating cancer unresponsive to pd-1/pd-l1 signaling inhibitor".

Company Profile

0.12.16

SUGIMOTO; Masamichi - Kanagawa JP
Sugimoto; Masamichi - Gotenba N/A JP
Sugimoto; Masamichi - Gotenba-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method And Medicament For Treating Cancer Unresponsive To Pd-1/pd-l1 Signaling Inhibitor App 20210388090 - ISHIKURA; Nobuyuki ; et al.	2021-12-16
Pharmaceutical Composition App 20210198364 - Iwai; Toshiki ; et al.	2021-07-01
Anti-glypican-3 antibody Grant 10,118,959 - Lazar , et al. November 6, 2	2018-11-06
Anti-glypican-3 antibody Grant 9,102,739 - Lazar , et al. August 11, 2	2015-08-11
Anti-Glypican-3 Antibody App 20150098941 - Lazar; Gregory Alan ; et al.	2015-04-09
Method for detection of liver cancer cell using anti-glypican-3 antibody Grant 8,663,929 - Kataoka , et al. March 4, 2	2014-03-04
Method for treating psoriasis by administering an antibody to interleukin-6 receptor Grant 8,597,644 - Ito , et al. December 3, 2	2013-12-03
Method of treating psoriatic arthritis with an IL-6 receptor antibody Grant 8,562,990 - Ito , et al. October 22, 2	2013-10-22
Preventive Or Therapeutic Agent For Psoriatic Arthritis Comprising Il-6 Antagonist As Active Ingredient App 20110268734 - Ito; Hiroaki ; et al.	2011-11-03
Liver Cancer Drug App 20110104157 - Kinoshita; Yasuko ; et al.	2011-05-05
Method For Detection Of Liver Cancer Cell Using Anti-glypican-3 Antibody App 20110091907 - Kataoka; Hiroaki ; et al.	2011-04-21
Anti-Glypican 3 Antibody Having Modified Sugar Chain App 20110033452 - Nakano; Kiyotaka ; et al.	2011-02-10
Adjuvant therapy with the use of anti-glypican 3 antibody Grant 7,871,613 - Kinoshita , et al. January 18, 2	2011-01-18
Anti-glypican 3 antibody having modified sugar chain Grant 7,867,734 - Nakano , et al. January 11, 2	2011-01-11
Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited App 20090061485 - Tsuchiya; Masayuki ; et al.	2009-03-05
Anti-Glypican-3 Antibody App 20080267979 - Lazar; Gregory Alan ; et al.	2008-10-30
Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited App 20080166756 - Tsuchiya; Masayuki ; et al.	2008-07-10
Preventive Or Therapeutic Agent For Psoriasis Comprising Il-6 Antagonist As Active Ingredient App 20080124325 - Ito; Hiroaki ; et al.	2008-05-29
Anti-Glypican 3 Antibody Having Modified Sugar Chain App 20080124330 - Nakano; Kiyotaka ; et al.	2008-05-29
Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist Grant 7,320,792 - Ito , et al. January 22, 2	2008-01-22
Adjuvant Therapy with the Use of Anti-Glypican 3 Antibody App 20070269444 - Kinoshita; Yasuko ; et al.	2007-11-22
Sugar-chain-altered anti-hm1.24 antibody App 20070142627 - Tsuchiya; Masayuki ; et al.	2007-06-21
Anti-glypican-3 antibody App 20070087005 - Lazar; Gregory Alan ; et al.	2007-04-19
Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist App 20040028681 - Ito, Hiroaki ; et al.	2004-02-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.